JOHNSON & JOHNSON

Official Publications Johnson & Johnson

Equities

JNJ

US4781601046

Market Closed - Nyse Other stock markets 04:00:02 2024-04-24 pm EDT			5-day change	1st Jan Change
148.5 ^USD	-0.69%		+2.60%	-5.24%

Apr. 24	Cidara Therapeutics Shares Surge 42% After Re-Acquiring Flu Asset	DJ
Apr. 24	Alvotech’s Simponi Biosimilar Candidate Shows Efficacy in Confirmatory Study	MT

Official Publications

SEC Filing 8K	Apr. 15	CO
Slide show Q1	Apr. 15	CO
1st quarter results	Apr. 15	CO
SEC Filing 13G	Apr. 09	CO
Proxy Statments	Mar. 12	CO
SEC Filing 10K	Feb. 15	CO
SEC Filing 13G	Jan. 23	CO
SEC Filing 8K	Jan. 22	CO
Slide show results	Jan. 22	CO
Annual results	Jan. 22	CO
SEC Filing 8K	Dec. 04	CO
SEC Filing 8K	Nov. 29	CO
SEC Filing 8K	Nov. 20	CO
SEC Filing 10Q-3	23-10-26	CO
SEC Filing 8K	23-10-19	CO
Slide show Q3	23-10-16	CO
3rd quarter results	23-10-16	CO
SEC Filing 8K	23-10-16	CO
SEC Filing 8K	23-08-29	CO
SEC Filing 8K	23-08-22	CO
SEC Filing 10Q-2	23-07-30	CO
SEC Filing 8K	23-07-27	CO
1st-half-year results	23-07-19	CO
SEC Filing 8K	23-07-19	CO
SEC Filing 8K	23-05-02	CO

1 2 3

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Headlines

Joseph Wolk, CFO of J&J: End of patent for its flagship drug

Joseph Wolk, CFO of J&J: End of patent for its flagship drug

January 23, 2024 at 12:30 pm EST

+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019

Replicate our performance

fermer